A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal

Norman J Carr1, Thomas D Cecil, Faheez Mohamed

  • 1*Peritoneal Malignancy Institute †North Hampshire Hospital, Basingstoke ‡Cellular Pathology, University Hospital Southampton, Southampton, UK §Frederick National Laboratory for Cancer Research, National Cancer Institute, Rockville, MD ∥Washington Cancer Institute, Washington Hospital Center, Washington, DC ¶Surgical Oncology, MD Anderson Cancer Center, Madrid, Spain.

Insights

This study established a consensus classification for appendiceal mucinous neoplasms and pseudomyxoma peritonei (PMP). New terminology and grading systems were defined to standardize diagnosis and reporting of these complex conditions.

Area of Science:

  • Gastroenterology and Surgical Pathology
  • Oncology
  • Pathology

Background:

  • Pseudomyxoma peritonei (PMP) classification and terminology for appendiceal mucinous neoplasia were historically contentious.
  • Lack of standardized definitions hindered consistent diagnosis and research comparison across institutions.

Framework:

  • An international modified Delphi consensus process was conducted to establish unified terminology and definitions.
  • New classifications for mucinous appendiceal neoplasia and PMP were developed, including grading systems and specific criteria for terms like 'mucinous adenocarcinoma'.

Implementation:

  • The consensus defined 'low-grade appendiceal mucinous neoplasm' and proposed 'high-grade appendiceal mucinous neoplasm' for lesions with atypia but no invasion.
  • Pathologic classification of PMP was standardized into low grade, high grade, and high grade with signet ring cells.
  • A checklist for pathologic reporting of PMP and appendiceal mucinous neoplasms was created.

Implications:

  • Adoption of these standardized classifications and definitions will enable uniform terminology across centers.
  • This uniformity will facilitate meaningful comparison of clinical outcomes and research findings for PMP and related appendiceal neoplasms.
  • The consensus aims to improve diagnostic accuracy and patient management through consistent pathological reporting.